跳至主要内容
临床试验/IRCT20200722048176N1
IRCT20200722048176N1尚未招募3 期

Comparison of the Effect of Empaglifluzin and Linagliptin on the Albuminuria of patients with diabetes mellitus type 2 patients

Arak University of Medical Sciences0 个研究点目标入组 60 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
尚未招募
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
30 years 至 75 years(—)
性别
All

入选标准

  • Age over 30 years and under 75 years
  • Type 2 diabetes
  • The patient has microalbuminuria

排除标准

  • uncontrolled blood pressure
  • uncontrolled blood sugar
  • heart failure
  • chronic liver disease
  • presence of hematuria
  • signs of active urinary and renal infection
  • uinary catheter
  • High stages of nephropathy
  • other kidney diseases that cause albuminuria such as glomerulonephritis
  • acute hospital conditions

研究者

相似试验